Aesthetic Medical International Holdings Group Limited (FRA:3FMA)

FRA:3FMA Statistics

Total Valuation

FRA:3FMA has a market cap or net worth of EUR 3.89 million. The enterprise value is 21.31 million.

Market Cap	3.89M
Enterprise Value	21.31M

Important Dates

The next estimated earnings date is Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+7.54%
Shares Change (QoQ)	+3.82%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	6.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.04
PB Ratio	-0.74
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.73, with an EV/FCF ratio of -9.15.

EV / Earnings	-3.28
EV / Sales	0.24
EV / EBITDA	2.73
EV / EBIT	33.46
EV / FCF	-9.15

Financial Position

The company has a current ratio of 0.31

Current Ratio	0.31
Quick Ratio	0.26
Debt / Equity	n/a
Debt / EBITDA	4.38
Debt / FCF	-14.67
Interest Coverage	0.60

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	0.66%
Return on Invested Capital (ROIC)	-7.68%
Return on Capital Employed (ROCE)	6.36%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	67,243
Profits Per Employee	-4,963
Employee Count	1,309
Asset Turnover	1.45
Inventory Turnover	23.06

Taxes

In the past 12 months, FRA:3FMA has paid 3.57 million in taxes.

Income Tax	3.57M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -69.15% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-69.15%
50-Day Moving Average	0.04
200-Day Moving Average	0.09
Relative Strength Index (RSI)	60.72
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:3FMA had revenue of EUR 88.02 million and -6.50 million in losses. Loss per share was -0.15.

Revenue	88.02M
Gross Profit	40.70M
Operating Income	637,460
Pretax Income	-3.01M
Net Income	-6.50M
EBITDA	7.81M
EBIT	637,460
Loss Per Share	-0.15

Balance Sheet

The company has 7.34 million in cash and 34.17 million in debt, with a net cash position of -26.83 million.

Cash & Cash Equivalents	7.34M
Total Debt	34.17M
Net Cash	-26.83M
Net Cash Per Share	n/a
Equity (Book Value)	-5.26M
Book Value Per Share	-0.07
Working Capital	-35.82M

Cash Flow

In the last 12 months, operating cash flow was -1.49 million and capital expenditures -840,570, giving a free cash flow of -2.33 million.

Operating Cash Flow	-1.49M
Capital Expenditures	-840,570
Depreciation & Amortization	3.09M
Net Borrowing	n/a
Free Cash Flow	-2.33M
FCF Per Share	n/a

Margins

Gross margin is 46.24%, with operating and profit margins of 0.72% and -7.38%.

Gross Margin	46.24%
Operating Margin	0.72%
Pretax Margin	-3.42%
Profit Margin	-7.38%
EBITDA Margin	8.87%
EBIT Margin	0.72%
FCF Margin	n/a

Dividends & Yields

FRA:3FMA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.54%
Shareholder Yield	-7.54%
Earnings Yield	-166.83%
FCF Yield	-59.82%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6